Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will report financial results for Q4 and full year 2023 on February 28, 2024. The company's management will host a webcast to discuss results, business developments, and outlook.
02/07/2024 - 08:00 AM
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2023 before market open on Wednesday, February 28, 2024.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio .
About Nautilus Biotechnology, Inc. www.nautilus.bio .
Media Contact
Investor Contact
When will Nautilus Biotechnology report financial results for Q4 and full year 2023?
Nautilus Biotechnology will report financial results on February 28, 2024.
What is the ticker symbol for Nautilus Biotechnology?
The ticker symbol for Nautilus Biotechnology is NAUT.
Where can I listen to the webcast of the conference call?
The webcast will be available on the 'Investors' section of the company website at www.nautilus.bio.
What time will the conference call begin?
The conference call will begin at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
What will the management discuss during the conference call?
The management will discuss the company's financial results, business developments, and outlook.
Nautilus Biotechnology Inc
NAUT Rankings
#2135 Ranked by Stock Gains
NAUT Stock Data
Industry
Analytical Laboratory Instrument Manufacturing
Sector
Manufacturing
About NAUT
born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
